EMSITA TRIO TABLET

About EMSITA TRIO TABLET

EMSITA TRIO TABLET is a tablet from EMCURE PHARMACEUTICALS LTD, available as 10 TABLETS. It contains DAPAGLIFLOZIN 10MG + SITAGLIPTIN 100MG + METFORMIN 500MG.

Common uses: Type 2 diabetes control; helps lower blood sugar when diet and exercise alone are not enough; combines three medicines for better glucose management.

Take it with water exactly as your doctor has advised, and follow the label or your doctor on whether it should be taken before or after food.

EMSITA TRIO TABLET is a prescription medicine: upload a valid doctor's prescription when you order, and our pharmacist checks it before dispatch.

Store it as directed on the pack, away from direct sunlight and moisture, and out of the reach of children.

Where other brands with the same composition (DAPAGLIFLOZIN 10MG + SITAGLIPTIN 100MG + METFORMIN 500MG) are available, MedZoneAI shows them on this page so you can compare prices before you buy.

Uses of EMSITA TRIO TABLET

• Type 2 diabetes control
• Helps lower blood sugar when diet and exercise alone are not enough
• Combines three medicines for better glucose management

Side effects of EMSITA TRIO TABLET

• Nausea, diarrhea or constipation
• Headache, dizziness
• Urinary tract infections
• Rare: low blood sugar, kidney problems

Precautions for EMSITA TRIO TABLET

• Tell your doctor if you have kidney or heart disease
• Not for Type 1 diabetes or diabetic ketoacidosis
• Avoid if pregnant or breastfeeding
• Regular blood tests needed
• Tell doctor about all other medicines